{"database": "lobbying", "table": "lobbying_filings_raw", "rows": [["f31f4c01-3089-4e2d-badd-e4cf576edac2", "Q1", 300856, "AMERICAN ACADEMY OF NEUROLOGY", 180423, "AMERICAN ACADEMY OF NEUROLOGY", 2008, "first_quarter", "2008-04-03T15:10:35-04:00", 50000.0, 0, 0, 0, "{\"url\": \"https://lda.senate.gov/api/v1/filings/f31f4c01-3089-4e2d-badd-e4cf576edac2/\", \"filing_uuid\": \"f31f4c01-3089-4e2d-badd-e4cf576edac2\", \"filing_type\": \"Q1\", \"filing_type_display\": \"1st Quarter - Report\", \"filing_year\": 2008, \"filing_period\": \"first_quarter\", \"filing_period_display\": \"1st Quarter (Jan 1 - Mar 31)\", \"filing_document_url\": \"https://lda.senate.gov/filings/public/filing/f31f4c01-3089-4e2d-badd-e4cf576edac2/print/\", \"filing_document_content_type\": \"text/html\", \"income\": null, \"expenses\": \"50000.00\", \"expenses_method\": \"b\", \"expenses_method_display\": \"Method B - Reporting amounts under section 6033(b)(8) of the Internal Revenue Code\", \"posted_by_name\": \"Michael J. Amery, Legislative Counsel\", \"dt_posted\": \"2008-04-03T15:10:35-04:00\", \"termination_date\": null, \"registrant_country\": \"United States of America\", \"registrant_ppb_country\": \"United States of America\", \"registrant_address_1\": \"1501 M St. NW\", \"registrant_address_2\": \"Seventh Floor\", \"registrant_different_address\": false, \"registrant_city\": \"WASHINGTON\", \"registrant_state\": \"DC\", \"registrant_zip\": \"20005\", \"registrant\": {\"id\": 300856, \"url\": \"https://lda.senate.gov/api/v1/registrants/300856/\", \"house_registrant_id\": 37735, \"name\": \"AMERICAN ACADEMY OF NEUROLOGY\", \"description\": \"Physician trade association\", \"address_1\": \"25 Massachusetts Avenue, NW\", \"address_2\": \"Suite 500J\", \"address_3\": null, \"address_4\": null, \"city\": \"Washington\", \"state\": \"DC\", \"state_display\": \"District of Columbia\", \"zip\": \"20001\", \"country\": \"US\", \"country_display\": \"United States of America\", \"ppb_country\": \"US\", \"ppb_country_display\": \"United States of America\", \"contact_name\": \"MAXWELL GOLDMAN\", \"contact_telephone\": \"+1 860-917-1742\", \"dt_updated\": \"2026-01-20T16:34:45.069003-05:00\"}, \"client\": {\"id\": 180423, \"url\": \"https://lda.senate.gov/api/v1/clients/180423/\", \"client_id\": 12, \"name\": \"AMERICAN ACADEMY OF NEUROLOGY\", \"general_description\": null, \"client_government_entity\": false, \"client_self_select\": true, \"state\": \"MN\", \"state_display\": \"Minnesota\", \"country\": \"US\", \"country_display\": \"United States of America\", \"ppb_state\": \"MN\", \"ppb_state_display\": \"Minnesota\", \"ppb_country\": \"US\", \"ppb_country_display\": \"United States of America\", \"effective_date\": \"2011-04-17\"}, \"lobbying_activities\": [{\"general_issue_code\": \"HCR\", \"general_issue_code_display\": \"Health Issues\", \"description\": \"S. 999/HR 474 Stop Stroke Act creating statewide stroke systems education and grant programs.\\nNIH  - advocate increased funding\\nS. 1568 Support the Newborn Screening for genetic issues\\nS. 358/HR493 Support Genetic Nondiscrimination Act to protect those vulnerable to discrimination.\", \"foreign_entity_issues\": \"\", \"lobbyists\": [{\"lobbyist\": {\"id\": 47067, \"prefix\": \"mr\", \"prefix_display\": \"MR.\", \"first_name\": \"MICHAEL\", \"nickname\": null, \"middle_name\": \"J\", \"last_name\": \"AMERY\", \"suffix\": \"esq\", \"suffix_display\": \"ESQ\"}, \"covered_position\": null, \"new\": false}], \"government_entities\": [{\"id\": 2, \"name\": \"HOUSE OF REPRESENTATIVES\"}, {\"id\": 1, \"name\": \"SENATE\"}]}, {\"general_issue_code\": \"VET\", \"general_issue_code_display\": \"Veterans\", \"description\": \"S. 2004/HR 2818 creating Epilepsy Centers of Excellence at the VA.\", \"foreign_entity_issues\": \"\", \"lobbyists\": [{\"lobbyist\": {\"id\": 47067, \"prefix\": \"mr\", \"prefix_display\": \"MR.\", \"first_name\": \"MICHAEL\", \"nickname\": null, \"middle_name\": \"J\", \"last_name\": \"AMERY\", \"suffix\": \"esq\", \"suffix_display\": \"ESQ\"}, \"covered_position\": null, \"new\": false}], \"government_entities\": [{\"id\": 2, \"name\": \"HOUSE OF REPRESENTATIVES\"}, {\"id\": 1, \"name\": \"SENATE\"}]}, {\"general_issue_code\": \"MMM\", \"general_issue_code_display\": \"Medicare/Medicaid\", \"description\": \"Physician Reimbursement under Medicare - prevent cut to physician payments\\nImaging Issues - ensuring access to neurologist performed imaging services\\nMedicare Part D - removing the exclusion of Barbiturates and Benzodiasopines from the formulary.\", \"foreign_entity_issues\": \"\", \"lobbyists\": [{\"lobbyist\": {\"id\": 47067, \"prefix\": \"mr\", \"prefix_display\": \"MR.\", \"first_name\": \"MICHAEL\", \"nickname\": null, \"middle_name\": \"J\", \"last_name\": \"AMERY\", \"suffix\": \"esq\", \"suffix_display\": \"ESQ\"}, \"covered_position\": null, \"new\": false}], \"government_entities\": [{\"id\": 2, \"name\": \"HOUSE OF REPRESENTATIVES\"}, {\"id\": 1, \"name\": \"SENATE\"}]}], \"conviction_disclosures\": [], \"foreign_entities\": [], \"affiliated_organizations\": []}"]], "columns": ["filing_uuid", "filing_type", "registrant_id", "registrant_name", "client_id", "client_name", "filing_year", "filing_period", "received_date", "amount_reported", "is_amendment", "is_no_activity", "is_termination", "raw_json"], "primary_keys": ["filing_uuid"], "primary_key_values": ["f31f4c01-3089-4e2d-badd-e4cf576edac2"], "units": {}, "query_ms": 0.4034879384562373, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}